Security key
78349D107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 9,110,247
- Total 13F value
- $109,310,492
- Share change
- -202,368
- SEC-reported price per share
- $12.00
- Number of holders
- 52
- Value change
- -$3,350,494
- Number of buys
- 30
- Number of sells
- 16
- Shares outstanding
- 41,319,174
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
52
Top holders
10
RXST full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
RxSight, Inc. SEC filings
RxSight, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78349D107
Recent filing periods:
Ownership snapshot
Top reported holders of RXST - RxSight, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RxSight I, LLC
Disclosed value leader
RxSight I, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2022
3/4/5
13F
Highest disclosed value: $96,806,554
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
RxSight I, LLC has the largest disclosed position value at $96.81M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RxSight I, LLC's linked filing trail.
Disclosed position value
Top 5
RxSight I, LLC
$96.81M
RA CAPITAL MANAGEMENT, L.P.
$42.98M
Richard M. Wolfen
$88.33M
Bruce C. Robertson
$66.48M
Daniel Mark Schwartz
$19.57M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RxSight I, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$96,806,554
2,016,778 shares
|
— | 03 Aug 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$42,983,000
3,052,796 shares
|
— | 30 Jun 2022 |
| Richard M. Wolfen |
3/4/5
Director
|
—
denominator unverified
|
$88,332,816
1,840,244 shares
|
— | 03 Aug 2021 |
| Bruce C. Robertson |
3/4/5
Director
|
—
denominator unverified
|
$66,482,607
1,385,037 shares
|
— | 03 Aug 2021 |
| Daniel Mark Schwartz |
3/4/5
Director
|
—
denominator unverified
|
$19,567,301
407,647 shares
|
— | 03 Aug 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$19,480,000
1,383,500 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
52
Shares
9,110,247
Rows available
52
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
47
Q3 2022 holders
52
Holder diff
5
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend